SPIRIT: Can a software system for tracking infection in a hospital become a “product”?

Tuesday, October 30, 2012 - 6:30pm

MedIntelInappropriate use of antimicrobials is a growing concern for hospitals worldwide. This has led to an increased prevalence of antimicrobial resistant organisms, a problem further exacerbated by the reduced development of novel antimicrobial therapies. Antimicrobials have been found to be inappropriately used in up to 50% of cases. The growing incidence of hospital-acquired infections has highlighted the pressing need for Antimicrobial Stewardship Programs (ASP). To address this issue, Accreditation Canada has made a mandate for hospitals to implement an ASP starting January 2013. The most successful ASPs have been shown to use software that increases the efficiency of an ASP team. SPIRIT is a multi-functional integration program that allows pharmacists to review relevant clinical data in real-time. Medium-sized hospitals across Canada have been identified as the target market for this software. However, significant costs associated with SPIRIT as well as purchasers’ budget constraints reduce its commercialization potential and profitability. A centralized server model is being proposed to achieve a competitive selling price and a fair profit margin for SPIRIT developers.

MedIntel: Brad Henderson, Jooyeon Christine Kim, Joyce Javier, Olena Skokovets.

Sorry, this presentation is NOT open to the public. 

The Master of Biotechnology Program would like to thank AstraZeneca Canada Inc. for their continued support of this seminar series.